Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Receivables (2012 - 2026)

Updated

Ani Pharmaceuticals (ANIP) reported Receivables of $274.47 million for Q2 2026, up 21.6% from $225.65 million a year earlier and up 7.5% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Receivables (2012 - 2026) Analysis & Trends

At the end of FY2025, Ani Pharmaceuticals posted Receivables of $281.08 million, up 26.8% from FY2024.

  • Receivables has a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
  • By year, Receivables came in at $221.73 million in FY2024 (+36.8%), $162.08 million in FY2023 (-2.0%), $165.44 million in FY2022 (+28.7%) and $128.53 million in FY2021 (+34.2%).
  • Five-year quarterly Receivables spans a low of $106.71 million in Q3 2021 and a high of $281.08 million in Q4 2025.
  • Year over year, Receivables has now increased in each of the last eight quarters, with growth averaging 25.4% over the last eight quarters.
  • The high point for year-over-year Receivables in five years was Q2 2022 (growth of 62.3%); the low point was Q2 2024 (a decline of 4.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $255.43 million (Q1 2026), $281.08 million (Q4 2025) and $252.62 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn 274.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 274.47 Mn
Mar 31, 2026 255.43 Mn
Dec 31, 2025 281.08 Mn
Sep 30, 2025 252.62 Mn
Jun 30, 2025 225.65 Mn
Mar 31, 2025 220.33 Mn
Dec 31, 2024 221.73 Mn
Sep 30, 2024 196.36 Mn
Jun 30, 2024 166.09 Mn
Mar 31, 2024 172.42 Mn
Dec 31, 2023 162.08 Mn
Sep 30, 2023 178.84 Mn
Jun 30, 2023 172.93 Mn
Mar 31, 2023 174.71 Mn
Dec 31, 2022 165.44 Mn
Sep 30, 2022 140.43 Mn
Jun 30, 2022 150.41 Mn
Mar 31, 2022 131.63 Mn
Dec 31, 2021 128.53 Mn
Sep 30, 2021 106.71 Mn
API Access

Ani Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ANIP&period=max&api_key=YOUR_API_KEY